The risk of a women developing a urinary tract infection in her lifetime is over 50%, approximately 25% of which become recurrent (rUTIs). This study examined the viewpoints of women with rUTIs through six focus groups at a tertiary centre...
Clinicians are well aware of the limitations of the so-called Kass criteria applied to standard urine culture (SUC) techniques as well as the limitations of empiric antibiotic prescribing for symptoms that are known to overlap with chronic conditions such as...
The optimal evaluation of non-visible haematuria (NVH) continues to be debated, with competing interests of avoidance underdiagnosis and the harms of over-testing. Current National Institute for Health & Care Excellent (NICE) guidance recommends referral for patients ≥60 years with NVH....
The concluding statement of this short review states, “the study of the urinary microbiome and its impact on urological disease, including IC/BPS, is in its infancy.” A lot has been said on this subject in recent years, but this, in...
Metachronous upper tract urothelial cancer (UTUC) is encountered in about 5% of patients after radical cystectomy (RC) with a median time to diagnosis of 24-36 months after RC, and most are asymptomatic and detected by surveillance protocols. In this multivariate...
Many of the side-effects and contra-indications of sildenafil and other phosphodiesterase 5 (PDE 5) inhibitors for erectile dysfunction have become well known to doctors and pharmacists over the years. This study from the United States collected case reports of adverse...
Patients with refractory overactive bladder (OAB) may be offered OnabotulinumtoxinA (Botox®) as one of the third-line options. Given the invasive nature of requiring cystoscopy, injections via a needle and local anaesthesia, it would be simpler, more convenient and more accessible...
Present your innovative research on the world stage! 🌟
Submit your abstract for SIU 2025 Edinburgh by April 3 2025, and be part of shaping the future of urology.
Click the image to access
You can now access the SIU 2024 B2B GU Cancers Triad proceedings, published as a supplement to the February issue of SIUJ. Review the latest updates on bladder, kidney and prostate cancers that were presented by expert faculty. Access the...
An exciting opportunity has arisen for a Full time Band 7 Urology Nurse Specialist to join The Birmingham Prostate Specialists Service in conjunction with HCA Harborne Hospital, Birmingham. (Part time would be considered) The post holder will be initially supported...
The Association for Continence Professionals Annual Conference and Networking Exhibition takes place 11 – 12 May, and the Association understand that rising costs and sector-wide pressures can make attending conferences challenging. Therefore, to help support attendance at this year’s conference...
Action Bladder Cancer UK is inviting nominations for its Nurse of the Year Award 2026, recognising the outstanding contribution of nurses who support people affected by bladder cancer. Do you know a nurse who has gone above and beyond? They...